Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01112722 | Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis | PHASE3 | COMPLETED | 363 | — | — | Dec 1, 2013 | Dec 1, 2016 | Dec 13, 2016 | 15 | United States, United States +13 |
| Name | Type | Description |
|---|---|---|
| Apitox, purified honeybee toxin, lyophilized in saline | BIOLOGICAL | intradermal injections of 0.1mg apitox in 0.1ml WFI over 12 weeks treatment period, injections twice weekly range from 1 to 20 injections |
| histamine | BIOLOGICAL | imitates pain and erythema of honeybee venom |